Response Announces Additional Chinese Partnership
Mon, 1 Feb 2010 13:00:00 UT
Response Biomedical Corporation announced that the Company has signed a second partner, Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) in China to sell the Company’s diagnostic products,... More...
  Response Pre-Announces 2009 Year-End Revenues
Mon, 11 Jan 2010 13:00:00 UT
Response Biomedical Corporation announced that the Company expects to report annual revenues of approximately $10 million in 2009, as compared to $5.876 million in 2008. The Company will ho... More...
  Response Receives European Patent Notice of Allowance for Key Component of Immunoassay...
Wed, 6 Jan 2010 13:00:00 UT
Response Biomedical Corporation announced today that the Company has received a Notice of Allowance from the European Patent Office for the patent entitled “Sensitive Immunochromatogr... More...
  Response Receives Further U.S. Patent and Trademark Office Notice of Allowance for Key...
Mon, 21 Dec 2009 13:00:00 UT
Response Biomedical Corporation announced that the Company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a continuation of the patent entitled ... More...
  Response Announces Third Quarter Results
Tue, 10 Nov 2009 12:00:00 UT
Response Biomedical Corporation today announced financial results for the third quarter and nine months ended September 30, 2009. Total revenues for the three and nine month periods ended S... More...
  Response to Release Q3 Financial Results on November 10, 2009
Tue, 3 Nov 2009 12:30:00 UT
Response Biomedical Corporation today announced that it will release its third quarter 2009 financial results on Tuesday, November 10, 2009. The Company will also host an analyst conference... More...
  Response Obtains Special 510(k) U.S. FDA Clearance to Add Analytical Reactivity Inform...
Thu, 22 Oct 2009 11:30:00 UT
Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company’s RAMP® Influenza A/B Assay Package I... More...
  Response to Present at Rodman & Renshaw Annual Global Investment Conference
Tue, 8 Sep 2009 12:01:00 UT
Response Biomedical Corporation announced today that S. Wayne Kay, Chief Executive Officer, will present a corporate update at the Rodman & Renshaw 11th Annual Healthcare Conference as ... More...
  Response Announced Second Quarter Results
Wed, 12 Aug 2009 11:45:00 UT
Response Biomedical Corporation reported that clinical products revenue for the three and six month periods ended June 30, 2009 increased 373%. More...
  Response To Present at BMO Capital Markets Focus on Healthcare Conference
Tue, 4 Aug 2009 18:33:00 UT
Response Biomedical Corporation announced today that S. Wayne Kay, Chief Executive Officer, will present at the BMO Capital Markets 9th Annual Focus on Healthcare. More...